The Food and Drug Administration (FDA) has approved HemiClor ™, a low dose formulation of chlorthalidone, for the treatment of hypertension in adults, to lower blood pressure.

Narsoplimab is a human monoclonal antibody that specifically targets mannan-binding lectin-associated serine protease-2.

Reproxalap is a first-in-class small-molecule modulator of reactive aldehyde species, which are generally elevated in ocular and systemic inflammatory disease.

Friede's passion nearly cost him his life in 2001, when he let 2 cobras bite him and ended up in a coma for four days.

Seven percent of 108 healthy volunteers reported urticaria; unresolved urticaria persisted at 12 months in four participants.

HealthDay News — More US children have died from the flu this season than in any year since the 2009 swine flu pandemic, according to a new federal report.

The patient's medical history included obesity, asthma, possible sleep apnea, and a potentially deviated septum.

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for milsaperidone (Bysanti™) for the treatment of acute ...

“Interchangeability of Selarsdi with Stelara will further enable increased access for US patients to more affordable treatment options and contribute to lowering health care costs, which is an ...

ATH434 is designed to reduce α-synuclein aggregation and oxidative stress by binding to and redistributing excess loosely bound iron in the brain.

HealthDay News — The US Department of Health and Human Services and the National Institutes of Health announced a new initiative called “Generation Gold Standard” to develop next-generation, universal ...

Doctors say for diseases like measles or polio, they argue it may be wrong to withhold vaccines from people in a placebo group when those vaccines have already been shown to be effective.